|
US3773319A
(en)
|
1971-12-16 |
1973-11-20 |
Fabcor Ind Inc |
Corrugated sheet inverting machine
|
|
US4444887A
(en)
*
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US4634665A
(en)
*
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
*
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
*
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4716111A
(en)
*
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
US4510245A
(en)
*
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
GB8308235D0
(en)
*
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
US6054561A
(en)
|
1984-02-08 |
2000-04-25 |
Chiron Corporation |
Antigen-binding sites of antibody molecules specific for cancer antigens
|
|
DE3572982D1
(en)
|
1984-03-06 |
1989-10-19 |
Takeda Chemical Industries Ltd |
Chemically modified lymphokine and production thereof
|
|
US4694778A
(en)
|
1984-05-04 |
1987-09-22 |
Anicon, Inc. |
Chemical vapor deposition wafer boat
|
|
US5807715A
(en)
*
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US5168062A
(en)
*
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
GB2183662B
(en)
|
1985-04-01 |
1989-01-25 |
Celltech Ltd |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
US4968615A
(en)
*
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5225539A
(en)
*
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
US5336603A
(en)
*
|
1987-10-02 |
1994-08-09 |
Genentech, Inc. |
CD4 adheson variants
|
|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
WO1989012624A2
(en)
|
1988-06-14 |
1989-12-28 |
Cetus Corporation |
Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom
|
|
AU4308689A
(en)
|
1988-09-02 |
1990-04-02 |
Protein Engineering Corporation |
Generation and selection of recombinant varied binding proteins
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
DE68913658T3
(de)
|
1988-11-11 |
2005-07-21 |
Stratagene, La Jolla |
Klonierung von Immunglobulin Sequenzen aus den variablen Domänen
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
ATE135370T1
(de)
|
1988-12-22 |
1996-03-15 |
Kirin Amgen Inc |
Chemisch modifizierte granulocytenkolonie erregender faktor
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5225538A
(en)
*
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
ZA902949B
(en)
|
1989-05-05 |
1992-02-26 |
Res Dev Foundation |
A novel antibody delivery system for biological response modifiers
|
|
EP0474727B1
(en)
|
1989-05-19 |
1997-07-23 |
Genentech, Inc. |
Her2 extracellular domain
|
|
US5413923A
(en)
*
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5180820A
(en)
|
1989-08-30 |
1993-01-19 |
Barde Yves Alain |
Brain-derived neurotrophic factor
|
|
US5605690A
(en)
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
JP3068180B2
(ja)
*
|
1990-01-12 |
2000-07-24 |
アブジェニックス インコーポレイテッド |
異種抗体の生成
|
|
US6150584A
(en)
*
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
WO1991014438A1
(en)
|
1990-03-20 |
1991-10-03 |
The Trustees Of Columbia University In The City Of New York |
Chimeric antibodies with receptor binding ligands in place of their constant region
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US5219837A
(en)
|
1990-06-21 |
1993-06-15 |
Trustees Of The University Of Pennsylvania |
Method of stimulating myelination of cells
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5532351A
(en)
|
1990-07-12 |
1996-07-02 |
Arch Development Corporation |
Nucleic acid sequences encoding OMGP
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
*
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
*
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
*
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
EP1149913A1
(en)
|
1990-11-09 |
2001-10-31 |
GILLIES, Stephen D. |
Cytokine immunoconjugates
|
|
US5252714A
(en)
*
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
DK0564531T3
(da)
*
|
1990-12-03 |
1998-09-28 |
Genentech Inc |
Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
|
|
ES2315612T3
(es)
|
1991-04-10 |
2009-04-01 |
The Scripps Research Institute |
Genotecas de receptores heterodimericos usando fagemidos.
|
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
|
WO1992022324A1
(en)
|
1991-06-14 |
1992-12-23 |
Xoma Corporation |
Microbially-produced antibody fragments and their conjugates
|
|
US5756096A
(en)
|
1991-07-25 |
1998-05-26 |
Idec Pharmaceuticals Corporation |
Recombinant antibodies for human therapy
|
|
MX9204374A
(es)
*
|
1991-07-25 |
1993-03-01 |
Idec Pharma Corp |
Anticuerpo recombinante y metodo para su produccion.
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
WO1993016177A1
(en)
|
1992-02-11 |
1993-08-19 |
Cell Genesys, Inc. |
Homogenotization of gene-targeting events
|
|
US5733743A
(en)
*
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
EP0627932B1
(en)
|
1992-11-04 |
2002-05-08 |
City Of Hope |
Antibody construct
|
|
EP0669986B1
(en)
|
1992-11-13 |
2003-04-09 |
Idec Pharmaceuticals Corporation |
Fully impaired consensus kozac sequences for mammalian expression
|
|
US5468872A
(en)
|
1993-09-16 |
1995-11-21 |
Cephalon, Inc. |
K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders
|
|
DK0730740T3
(da)
|
1993-11-23 |
1998-09-28 |
Genentech Inc |
Kinasereceptoraktiveringsassay
|
|
US5753225A
(en)
|
1993-12-03 |
1998-05-19 |
The Regents Of The University Of California |
Antibodies that mimic actions of neurotrophins
|
|
JPH09506262A
(ja)
|
1993-12-08 |
1997-06-24 |
ジェンザイム・コーポレイション |
特異的抗体の製造方法
|
|
ES2247204T3
(es)
|
1994-01-31 |
2006-03-01 |
Trustees Of Boston University |
Bancos de anticuerpos policlonales.
|
|
GB9402331D0
(en)
|
1994-02-07 |
1994-03-30 |
Univ Mcgill |
Nerve growth factor structural analogs and their uses
|
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
|
DE4447588C2
(de)
|
1994-05-03 |
1997-11-20 |
Omer Osama Dr Dr Med |
Pflanzliches Arzneimittel zur Behandlung von chronischen und allergischen Rhino-Sino-Bronchitiden
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
HU226980B1
(en)
|
1994-10-25 |
2010-04-28 |
Toyama Chemical Co Ltd |
Use of 1,2-ethanediol derivatives or salts thereof for the preparation of pharmaceutical compositions having nerve growth factor (nfg) potentiator activity
|
|
US5770577A
(en)
|
1994-11-14 |
1998-06-23 |
Amgen Inc. |
BDNF and NT-3 polypeptides selectively linked to polyethylene glycol
|
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
|
US6280964B1
(en)
|
1995-04-14 |
2001-08-28 |
The Regents Of The University Of California |
Binding sites for phosphotyrosine binding domains
|
|
DE69637481T2
(de)
|
1995-04-27 |
2009-04-09 |
Amgen Fremont Inc. |
Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
|
|
AU2466895A
(en)
|
1995-04-28 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5811524A
(en)
*
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
AU6113396A
(en)
|
1995-06-14 |
1997-01-15 |
Regents Of The University Of California, The |
Novel high affinity human antibodies to tumor antigens
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
IT235676Y1
(it)
|
1995-07-27 |
2000-07-12 |
Felice Gaudioso |
Allestimenti per lo svolgimento del gioco wormhole action match.
|
|
GB9525180D0
(en)
|
1995-12-08 |
1996-02-07 |
Univ Mcgill |
Design of hormone-like antibodies with agonistic and antagonistic fuctions
|
|
JP2978435B2
(ja)
*
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
US6455277B1
(en)
|
1996-04-22 |
2002-09-24 |
Amgen Inc. |
Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
|
|
JP2000501416A
(ja)
|
1996-04-26 |
2000-02-08 |
ユニバーシティー オブ オタワ |
ニューロン病を治療し予防するための、治療法および薬物のスクリーニング法
|
|
EP0912184B1
(en)
|
1996-06-25 |
2002-09-25 |
Cephalon, Inc. |
Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction
|
|
BR9710357A
(pt)
*
|
1996-07-12 |
1999-08-17 |
Genentech Inc |
Adesina heteromultimera quimerica recomvinante isolada sequencia de acido nucleiro isolada acido nucleico isolado vetor celula hospedeira anticorpo metodo para formar um complexo adesina-ligante heteromultimera quimerica metodo para inibir a ativa-ao metodo para ativar um receptor hetermultimerico natural composicao farmaceutica artigo manufaturado e metodo para produzir anticorpo
|
|
EP0938499A1
(en)
|
1996-07-19 |
1999-09-01 |
Amgen Inc. |
Analogs of cationic proteins
|
|
WO1998011243A2
(en)
*
|
1996-09-11 |
1998-03-19 |
The General Hospital Corporation |
Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
|
|
WO1998010785A1
(fr)
|
1996-09-13 |
1998-03-19 |
Advanced Medicine Research Institute |
Compositions ophtalmiques de facteurs neurotrophiques, remedes pour troubles fonctionnels du nerf optique et procede de traitement de tels troubles
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
US6420140B1
(en)
|
1996-10-11 |
2002-07-16 |
Abgenix, Inc. |
Production of multimeric protein by cell fusion method
|
|
US20070213290A1
(en)
|
1996-10-17 |
2007-09-13 |
Kingsman Alan J |
Neurite regeneration
|
|
US6593290B1
(en)
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
|
US6156728A
(en)
|
1996-11-01 |
2000-12-05 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
|
KR20080059467A
(ko)
|
1996-12-03 |
2008-06-27 |
아브게닉스, 인크. |
복수의 ｖｈ 및 ｖｋ 부위를 함유하는 사람 면역글로불린유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된항체
|
|
PL191251B1
(pl)
|
1997-03-14 |
2006-04-28 |
Idec Pharma Corp |
Sposób wprowadzania żądanego DNA w docelowe miejsce w genomie ssaka i układ wektorów
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO1998046645A2
(en)
|
1997-04-14 |
1998-10-22 |
Micromet Gesellschaft Für Biomedizinische Forschung Mbh |
Method for the production of antihuman antigen receptors and uses thereof
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
JP2002512624A
(ja)
|
1997-05-21 |
2002-04-23 |
バイオベーション リミテッド |
非免疫原性タンパク質の製造方法
|
|
WO1999004705A1
(en)
|
1997-07-25 |
1999-02-04 |
Tsui Ban C H |
Devices, systems and methods for determining proper placement of epidural catheters
|
|
US20020112251A1
(en)
*
|
1997-08-04 |
2002-08-15 |
Mccarthy Sean A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
|
|
WO1999006427A1
(en)
|
1997-08-04 |
1999-02-11 |
Millennium Biotherapeutics, Inc. |
Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
|
|
NZ503343A
(en)
|
1997-09-17 |
2002-09-27 |
Genentech Inc |
Secreted and transmembrane polypeptides and use to induce apoptosis of tumour cells
|
|
US6974689B1
(en)
*
|
1997-09-18 |
2005-12-13 |
Genentech, Inc. |
Nucleic acid encoding PRO211 polypeptides
|
|
ATE310810T1
(de)
*
|
1997-10-24 |
2005-12-15 |
Genentech Inc |
Polypeptid und dafür kodierendes nukeinsäure
|
|
FR2776661B1
(fr)
|
1998-03-26 |
2002-04-05 |
Centre Nat Rech Scient |
Polypeptide immunoreactif du recepteur trka du ngf et utilisations
|
|
US7282482B2
(en)
|
1998-04-08 |
2007-10-16 |
The Regents Of The University Of California |
NGF for the prevention of demyelination in the nervous system
|
|
CA2343577A1
(en)
|
1998-09-16 |
2000-03-23 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
PL204293B1
(pl)
|
1998-11-06 |
2009-12-31 |
Univ Zuerich |
Oczyszczone białko i jego zastosowanie, izolowany kwas nukleinowy, wektor do klonowania, rekombinowana komórka, sposób wytwarzania rekombinowanego białka, sposób identyfikacji rybozymu lub antysensownego kwasu nukleinowego, przeciwciało monoklonalne, zastosowanie przeciwciała, sposób wytwarzania przeciwciał poliklonalnych, izolowana próbka surowicy odpornościowej, zastosowanie surowicy odpornościowej i sposób wytwarzania przeciwciał monoklonalnych.
|
|
EP1051432B1
(en)
|
1998-12-08 |
2007-01-24 |
Biovation Limited |
Method for reducing immunogenicity of proteins
|
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
US20040067490A1
(en)
*
|
2001-09-07 |
2004-04-08 |
Mei Zhong |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
DE60028970T2
(de)
|
1999-07-02 |
2007-02-15 |
Genentech Inc., San Francisco |
An her2 bindende peptidverbindungen
|
|
AU2883900A
(en)
|
1999-07-07 |
2001-01-30 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1074617A3
(en)
|
1999-07-29 |
2004-04-21 |
Research Association for Biotechnology |
Primers for synthesising full-length cDNA and their use
|
|
WO2001009317A1
(fr)
|
1999-07-29 |
2001-02-08 |
Helix Research Institute |
Gene associe au cancer de l'estomac
|
|
EP1206543A2
(en)
|
1999-08-17 |
2002-05-22 |
Incyte Genomics, Inc. |
Membrane associated proteins
|
|
US6461414B1
(en)
|
1999-10-29 |
2002-10-08 |
Baker Hughes Incorporated |
Foam monitoring and control system
|
|
CA2490909A1
(en)
|
1999-12-01 |
2001-06-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6680209B1
(en)
|
1999-12-06 |
2004-01-20 |
Biosite, Incorporated |
Human antibodies as diagnostic reagents
|
|
US6977723B2
(en)
*
|
2000-01-07 |
2005-12-20 |
Transform Pharmaceuticals, Inc. |
Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
|
|
AU784349C
(en)
|
2000-01-12 |
2006-09-28 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
|
US7119165B2
(en)
*
|
2000-01-12 |
2006-10-10 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
|
ATE340571T1
(de)
|
2000-01-18 |
2006-10-15 |
Univ Mcgill |
Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen
|
|
WO2001055333A2
(en)
|
2000-01-25 |
2001-08-02 |
Hyseq, Inc. |
Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
|
|
WO2001059063A2
(en)
|
2000-01-31 |
2001-08-16 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
WO2001055208A1
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
WO2001055317A2
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
AU2001236663A1
(en)
|
2000-02-03 |
2001-08-14 |
Nuvelo, Inc. |
Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides
|
|
EP1264844A4
(en)
|
2000-02-29 |
2004-08-18 |
Ltt Bio Pharma Co Ltd |
BDNF MODIFIED
|
|
EP1272647B1
(en)
|
2000-04-11 |
2014-11-12 |
Genentech, Inc. |
Multivalent antibodies and uses therefor
|
|
WO2002000677A1
(en)
|
2000-06-07 |
2002-01-03 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
US6430914B1
(en)
|
2000-06-29 |
2002-08-13 |
Foster Wheeler Energy Corporation |
Combined cycle power generation plant and method of operating such a plant
|
|
US20040010118A1
(en)
|
2000-08-16 |
2004-01-15 |
Zerhusen Bryan D. |
Novel proteins and nucleic acids encoding same
|
|
WO2002022802A1
(en)
|
2000-09-13 |
2002-03-21 |
Smithkline Beecham Corporation |
Novel compounds
|
|
US20040048245A1
(en)
|
2000-10-05 |
2004-03-11 |
Shimkets Richard A. |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
|
NZ525422A
(en)
|
2000-10-06 |
2006-09-29 |
Biogen Idec Inc |
Isolated polynucleotides comprising a nucleic acid which encodes a polypeptide which modulates axonal growth in CNS neurons
|
|
WO2002102855A2
(en)
|
2000-11-17 |
2002-12-27 |
University Of Rochester |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
|
ES2295218T3
(es)
|
2000-12-01 |
2008-04-16 |
Central Institute For Experimental Animals |
Procedimiento para la produccion de un raton adecuado para el prendimiento, la diferenciacion y la proliferacion de celulas heterogeneas, raton producido mediante este procedimiento y utilizacion del raton.
|
|
US20030216558A1
(en)
|
2000-12-22 |
2003-11-20 |
Morris David W. |
Novel compositions and methods for cancer
|
|
AU2002255478A1
(en)
|
2001-01-10 |
2002-09-12 |
Pe Corporation (Ny) |
Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
|
|
NZ545176A
(en)
|
2001-01-29 |
2008-05-30 |
Biogen Idec Inc |
Modified antibodies reactive with CD20 and methods of use
|
|
WO2002096948A2
(en)
|
2001-01-29 |
2002-12-05 |
Idec Pharmaceuticals Corporation |
Engineered tetravalent antibodies and methods of use
|
|
WO2003008583A2
(en)
|
2001-03-02 |
2003-01-30 |
Sagres Discovery |
Novel compositions and methods for cancer
|
|
WO2002099116A2
(en)
|
2001-06-04 |
2002-12-12 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
US20030162734A1
(en)
|
2001-06-28 |
2003-08-28 |
Miller Carol A. |
Modulation of DENN-MADD expression and interactions for treating neurological disorders
|
|
US7223558B2
(en)
|
2001-07-11 |
2007-05-29 |
Bristol-Myers Squibb Company |
Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
|
|
US20030226155A1
(en)
|
2001-08-30 |
2003-12-04 |
Biorexis Pharmaceutical Corporation |
Modified transferrin-antibody fusion proteins
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
US20050123990A1
(en)
*
|
2001-09-26 |
2005-06-09 |
Incyte Corporation |
Membrane associated proteins
|
|
AU2002365258A1
(en)
|
2001-10-12 |
2003-09-02 |
University Of Vermont And State Agricultural College |
Binding peptides specific for the extracellular domain of erbb2 and uses therefor
|
|
WO2003035833A2
(en)
|
2001-10-22 |
2003-05-01 |
Exelixis, Inc. |
Modifier of the p53 pathway and methods of use
|
|
US7309485B2
(en)
|
2001-12-03 |
2007-12-18 |
Children's Medical Center Corporation |
Reducing myelin-mediated inhibition of axon regeneration
|
|
WO2003054152A2
(en)
|
2001-12-10 |
2003-07-03 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
US20030219795A1
(en)
|
2002-03-01 |
2003-11-27 |
Marcia Belvin |
SCDs as modifiers of the p53 pathway and methods of use
|
|
MXPA04009681A
(es)
|
2002-04-05 |
2005-01-11 |
Amgen Inc |
Anticuerpos humanos neutralizantes anti-ligando de osteoprotegerina como inhibidores selectivos de la ruta del ligando de osteoprotegerina.
|
|
US7077522B2
(en)
|
2002-05-03 |
2006-07-18 |
University Of Rochester |
Sharpness metric for vision quality
|
|
US6794785B2
(en)
|
2002-06-26 |
2004-09-21 |
Denso Corporation |
Alternator for vehicles
|
|
ATE469913T1
(de)
|
2002-08-10 |
2010-06-15 |
Univ Yale |
Antagonisten des nogo-rezeptors
|
|
NZ538569A
(en)
|
2002-09-06 |
2009-02-28 |
Amgen Inc |
Therapeutic human anti-IL-1R1 monoclonal antibody
|
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
|
US7816497B2
(en)
|
2002-10-30 |
2010-10-19 |
University Of Kentucky |
Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration
|
|
US20040186044A1
(en)
|
2002-11-06 |
2004-09-23 |
Cosgaya Jose Miguel |
Modulation of myelination by interaction with P75 and TRK receptors
|
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
|
PL1606409T3
(pl)
|
2003-03-19 |
2011-02-28 |
Biogen Ma Inc |
Białko wiążące receptor Nogo
|
|
JP2007501612A
(ja)
|
2003-08-07 |
2007-02-01 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｎｏｇｏ受容体アンタゴニスト
|
|
WO2005018572A2
(en)
|
2003-08-22 |
2005-03-03 |
Biogen Idec Ma Inc. |
Improved antibodies having altered effector function and methods for making the same
|
|
JP2007512001A
(ja)
|
2003-08-28 |
2007-05-17 |
バイオレクシス ファーマシューティカル コーポレイション |
Ｅｐｏミメティックペプチドおよび融合タンパク質
|
|
US7205387B2
(en)
|
2003-08-28 |
2007-04-17 |
Agency For Science, Technology And Research |
Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist
|
|
US7288638B2
(en)
|
2003-10-10 |
2007-10-30 |
Bristol-Myers Squibb Company |
Fully human antibodies against human 4-1BB
|
|
WO2005063819A2
(en)
|
2003-12-23 |
2005-07-14 |
Crucell Holland B.V. |
Human binding molecule against cd1a
|
|
WO2005079566A2
(en)
|
2004-02-12 |
2005-09-01 |
Lexicon Genetics Incorporated |
Gene disruptions, compositions and methods relating thereto
|
|
US7973139B2
(en)
*
|
2004-03-26 |
2011-07-05 |
Human Genome Sciences, Inc. |
Antibodies against nogo receptor
|
|
US20050214288A1
(en)
*
|
2004-03-26 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies against Nogo receptor
|
|
US20060034840A1
(en)
|
2004-04-08 |
2006-02-16 |
Agus David B |
ErbB antagonists for pain therapy
|
|
JP4960865B2
(ja)
|
2004-06-24 |
2012-06-27 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
脱髄に関連する状態の処置
|
|
US20060009288A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Devos John A |
Conveying information to an interrogator using resonant and parasitic radio frequency circuits
|
|
EP1789070B1
(en)
|
2004-08-03 |
2012-10-24 |
Biogen Idec MA Inc. |
Taj in neuronal function
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
AR054260A1
(es)
|
2005-04-26 |
2007-06-13 |
Rinat Neuroscience Corp |
Metodos de tratamiento de enfermedades de la neurona motora inferior y composiciones utilizadas en los mismos
|
|
JP2008540339A
(ja)
|
2005-04-29 |
2008-11-20 |
ワイス |
Ｎｏｇｏレセプター機能モチーフおよびそれに関するペプチド模倣物、ならびにそれらを使用する方法
|
|
CA2609077A1
(en)
|
2005-05-16 |
2006-12-28 |
Mcgill University |
Lgi, lingo and p75ntr family members: novel modulators of neuronal growth
|
|
CA2610771A1
(en)
|
2005-06-06 |
2006-12-14 |
Wyeth |
Anti-trkb monoclonal antibodies and uses thereof
|
|
EP2526942B1
(en)
|
2005-06-08 |
2017-08-09 |
The University of North Carolina At Chapel Hill |
Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
|
|
JP2008543790A
(ja)
|
2005-06-16 |
2008-12-04 |
ユニバーシティー・テクノロジーズ・インターナショナル・インコーポレイテッド |
短腸症候群の治療
|
|
SI1904104T1
(sl)
|
2005-07-08 |
2013-12-31 |
Biogen Idec Ma Inc. |
Protitelesa SP35 in njihova uporaba
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US20090175846A1
(en)
|
2005-10-27 |
2009-07-09 |
Biogen Idec Ma Inc |
Oligodendrocyte-Myelin Glycoprotein Compositions and Methods of Use Thereof
|
|
JP2009517340A
(ja)
*
|
2005-11-04 |
2009-04-30 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
ドーパミン作動性ニューロンの神経突起成長および生存を促進するための方法
|
|
NZ598421A
(en)
*
|
2005-12-02 |
2013-11-29 |
Biogen Idec Inc |
Treatment of Conditions Involving Demyelination
|
|
WO2007092777A2
(en)
|
2006-02-02 |
2007-08-16 |
Wyeth |
Cloning, characterization, and application of tnfrsf19 in neurological disorders
|
|
US7693698B2
(en)
|
2006-02-03 |
2010-04-06 |
Wyeth Llc |
Method for identifying or designing a candidate agent that interacts with LINGO-1 polypeptide using a LINGO-1 three-dimensional structure
|
|
WO2007098283A2
(en)
|
2006-02-27 |
2007-08-30 |
Biogen Idec Ma Inc. |
Use of antagonists of maif receptor complex molecules and neurotrophic factors for treatment of neurological diseases and disorders
|
|
WO2008013782A2
(en)
|
2006-07-24 |
2008-01-31 |
Biogen Idec Ma Inc. |
Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of sp35 or trka antagonists
|
|
CN103351437A
(zh)
|
2006-11-17 |
2013-10-16 |
诺瓦提斯公司 |
Lingo结合分子及其制药用途
|
|
US8128926B2
(en)
|
2007-01-09 |
2012-03-06 |
Biogen Idec Ma Inc. |
Sp35 antibodies and uses thereof
|
|
WO2008086006A2
(en)
|
2007-01-09 |
2008-07-17 |
Biogen Idec Ma Inc. |
Sp35 antibodies and uses thereof
|
|
EP2205071B1
(en)
*
|
2007-10-11 |
2015-07-22 |
Biogen MA Inc. |
Lingo-1 antagonists and trkb agonists for use in the treatment of glaucoma
|
|
CN101918540B
(zh)
|
2007-11-08 |
2016-05-11 |
比奥根Ma公司 |
Lingo-4拮抗剂在治疗涉及脱髓鞘的疾患中的应用
|
|
DK2732823T3
(da)
|
2008-06-25 |
2019-09-16 |
H Lundbeck As |
Modulering af TrpV : Vps10p-domæne-receptorsystemet til behandlingen af smerte
|
|
CA2729749A1
(en)
|
2008-07-02 |
2010-01-07 |
Emergent Product Development Seattle, Llc |
Tnf-a antagonist multi-target binding proteins
|
|
CA2729961C
(en)
*
|
2008-07-09 |
2018-05-01 |
Biogen Idec Ma Inc. |
Li113, li62 variant co2, anti-lingo antibodies
|
|
US8541170B2
(en)
|
2008-11-17 |
2013-09-24 |
Veracyte, Inc. |
Methods and compositions of molecular profiling for disease diagnostics
|
|
FR2958293B1
(fr)
|
2010-04-01 |
2014-09-26 |
Centre Nat Rech Scient |
Outils pour l'identification de ligands de lingo-1,lingo-2, lingo-3 et lingo-4, et utilisations
|
|
MX2014013950A
(es)
|
2012-05-14 |
2015-02-17 |
Biogen Idec Inc |
Antagonistas de proteina que interactua con el receptor nogo 2 que contiene repeticion rica en leucina y dominio de inmunoglobulina (lingo-2) para el tratamiento de afecciones que involucran neuronas motoras.
|